Cingulate CING
NASDAQ CING
$4.66 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cingulate (CING) Gains from Investment Securities (2025 - 2026)

Updated

Analysis

Cingulate (CING) Gains from Investment Securities (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Cingulate 64.75 Mn 9.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -314,013.00
Jun 30, 2025 -194,526.00
API Access

Cingulate Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=CING&period=max&api_key=YOUR_API_KEY